DDX53 and neoplasm: Similar to the CT26 model, cell-autonomous IRE1α KO in EMT6 cells had minimal impact on tumor growth (Fig. S6, A and B), identifying an additional suitable model for interrogating the impact of IRE1α inhibition on immune modulation.